NFKB1 and hepatocellular carcinoma: Moreover, as the key node of IRAK1/TRAF6/NF-κB signaling, IRAK1 is rarely investigated in terms of screening of natural compounds for potential inhibitors and signaling suppressors to be used in the targeted therapy of hepatocellular carcinoma.